Shuang Li1, Bingbing Qiu1, Hong Lu2, Yunshi Lai1, Jixing Liu1, Jiajun Luo1, Fengxin Zhu1, Zheng Hu1, Miaomiao Zhou1, Jianwei Tian1, Zhanmei Zhou1, Shouyi Yu2, Fan Yi3, Jing Nie1. 1. 1 State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Key Laboratory of Organ Failure Research (Ministry of Education), Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China. 2. 2 Department of Public Health, School of Public Health, Southern Medical University, Guangzhou, China. 3. 3 Department of Pharmacology, Shandong University School of Medicine, Jinan, China.
Abstract
AIMS: The risk factors promoting acute kidney injury (AKI) to chronic kidney disease (CKD) progression remain largely unknown. The aim of the present study was to investigate whether hyperhomocysteinemia (Hhcy) accelerates the development of renal fibrosis after AKI. RESULTS: Hhcy aggravated ischemia-reperfusion-induced AKI and the subsequent development of renal fibrotic lesions characterized by excessive extracellular matrix deposition. Mechanistically, the RNA binding protein human antigen R (HuR) bound to the 3'-untranslated region (3'-UTR) of heme oxygenase-1 (HO-1) messenger RNA (mRNA). Homocysteine (Hcy) downregulated HuR expression, reduced the binding of HuR to the 3'-UTR of HO-1, and thereafter decreased HO-1 expression. Administration of the HO-1 inducer cobalt protoporphyrin-IX significantly hindered Hhcy-augmented reactive oxygen species production and renal fibrotic lesions. Innovation and Conclusion: These data indicate that Hhcy might be a novel risk factor that promotes AKI to CKD progression. Lowering Hcy level or HO-1 induction might be a potential therapeutic strategy to improve the outcome of AKI.
AIMS: The risk factors promoting acute kidney injury (AKI) to chronic kidney disease (CKD) progression remain largely unknown. The aim of the present study was to investigate whether hyperhomocysteinemia (Hhcy) accelerates the development of renal fibrosis after AKI. RESULTS: Hhcy aggravated ischemia-reperfusion-induced AKI and the subsequent development of renal fibrotic lesions characterized by excessive extracellular matrix deposition. Mechanistically, the RNA binding protein human antigen R (HuR) bound to the 3'-untranslated region (3'-UTR) of heme oxygenase-1 (HO-1) messenger RNA (mRNA). Homocysteine (Hcy) downregulated HuR expression, reduced the binding of HuR to the 3'-UTR of HO-1, and thereafter decreased HO-1 expression. Administration of the HO-1 inducer cobalt protoporphyrin-IX significantly hindered Hhcy-augmented reactive oxygen species production and renal fibrotic lesions. Innovation and Conclusion: These data indicate that Hhcy might be a novel risk factor that promotes AKI to CKD progression. Lowering Hcy level or HO-1 induction might be a potential therapeutic strategy to improve the outcome of AKI.
Authors: María Piñeiro-Ramil; Elena F Burguera; Tamara Hermida-Gómez; Beatriz Caramés; Natividad Oreiro-Villar; Rosa Meijide-Faílde; Francisco J Blanco; Carlos Vaamonde-García Journal: Antioxidants (Basel) Date: 2022-03-25
Authors: Mei Zhang; Jing Yuan; Rong Dong; Jingjing Da; Qian Li; Ying Hu; Fangfang Yu; Yan Ran; Yan Zha; Yanjun Long Journal: Open Life Sci Date: 2021-05-29 Impact factor: 0.938
Authors: Andong Ji; Chunlei Pan; Hongxia Wang; Zhezhen Jin; Joseph H Lee; Qincheng Wu; Qixiao Jiang; Lianhua Cui Journal: Int J Environ Res Public Health Date: 2019-11-09 Impact factor: 3.390